Ulcerative Colitis Clinical Trials - Enhancing Care and the Future of Treatment

Join FOMAT Medical Research in the world of Ulcerative Colitis Clinical Trials. We are focused on developing new treatments for Ulcerative Colitis through clinical trials. We help individuals looking for new treatments and companies looking to partner in research.

Colorectal cancer treatment

What is Ulcerative Colitis?

Ulcerative colitis (UC) is a chronic condition in which the colon and rectum become inflamed and ulcers are developed. It’s an inflammatory bowel disease (IBD) along with Crohn’s disease. UC affects the lining of the large intestine and rectum, causing swelling, redness, and sores or ulcers. The course of UC can vary greatly from person to person - some may have mild symptoms while others may have life-altering complications.

Understanding Ulcerative Colitis

Symptoms

  • Abdominal pain and cramping from the inflammation and ulcers in the colon.
  • Frequent and urgent bowel movements from the irritation in the colon and rectum.
  • Blood in the stool, which may be bright red or dark, indicates bleeding in the colon.
  • Fatigue is when the body is using up its resources to fight inflammation and possibly from blood loss.
  • Weight loss and loss of appetite as eating may trigger discomfort or pain.

Causes and Risk Factors

What Causes Ulcerative Colitis?

Overview

The exact cause of Ulcerative Colitis is unknown but it’s thought to be an abnormal response of the immune system to gut bacteria.

Genetic

Family history increases the risk, so genetics plays a big role in the susceptibility to the disease.

Environmental and Immune System

Diet, pollution, and stress, among others, can trigger or worsen symptoms, showing the connection between environment and immunity.

Lifestyle

Smoking, diet, and physical activity can affect the course of the disease, so lifestyle changes are part of the overall care.

Ulcerative Colitis Complications: What are the Clinical Issues

Early Detection is Important

Early diagnosis and management are key to preventing complications and improving the quality of life for those affected.

Short-Term Complications During Active Disease

  • Dehydration and malnutrition from fluid and nutrient loss.
  • Severe bleeding and anemia from ulcers.
  • Toxic Megacolon is a rare but life-threatening dilation of the colon.

Long-Term Complications and Risks

  • Colorectal Cancer is higher in patients.
  • Osteoporosis from malabsorption of calcium and vitamin D.
  • Liver and kidney problems stem from chronic inflammation and side effects from medication.

What are Clinical Trials?

Clinical trials are research studies in people to evaluate a medical, surgical, or behavioral intervention. They are the way researchers find out if new treatments like drugs, diet, or medical devices are safe and effective in humans. In the case of Ulcerative Colitis, clinical trials are looking for new ways to treat, diagnose, and understand the disease. Joining a clinical trial means you can be part of medical research and possibly get access to the new treatment before it’s available to the public.

Why Join a Clinical Trial?

Joining a clinical trial has many benefits. For one, you get access to new treatments for Ulcerative Colitis that are not yet available to the public. This may mean personal health improvement when standard treatment has failed. Secondly, you provide valuable information that will help researchers understand Ulcerative Colitis better and improve management and care. By joining a clinical trial, you are part of the development of new medical interventions that will benefit future patients. Clinical trials usually provide participants with close monitoring by healthcare professionals so they get extra care.

Our Studies

We have several clinical trials for ulcerative colitis. Join and get access to new treatment and be part of medical research. Visit our page for all active ulcerative colitis trials.

  • Camarillo, Oxnard

    Ulcerative Colitis

    Ulcerative Colitis, a form of Inflammatory Bowel Disease (IBD), leads to inflammation, ulcers, and stomach discomfort. We are currently running a clinical study to test the effectiveness and safety of a new Alfa Induction Therapy for individuals suffering from Ulcerative Colitis.

    Criteria & Qualifications: • Must be 18 years old or above.
    • Recently diagnosed with Ulcerative Colitis within the past 3 months.
    • Agreeable to submit medical history documentation.

    Compensation: Contact us for more information

    Read more
  • Arcadia, Glendora, Monrovia, Oxnard, Pasadena

    Ulcerative Colitis Study

    Ulcerative Colitis causes inflammation and ulcers in the colon, resulting in abdominal discomfort. This study evaluates a new treatment's efficacy and safety for those with moderate to severe conditions. It targets individuals unsatisfied with or affected by current therapies' side effects.

    Criteria & Qualifications: • Is at least 18 years of age or older.
    • Diagnosed with Ulcerative Colitis.
    • Is willing to provide medical records.

    Compensation: Contact Us For More information

    Read more
  • Santa Maria

    Ulcerative Colitis Study

    Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.   Criteria & Qualifications: • Is at least 16 years of age or older. • Is willing to provide medical records. • Must have active symptoms, such as rectal bleeding.   Compensation: Contact us for more information

    Read more

FAQs

Length of a clinical trial depends on many factors such as the disease and the medicine being studied. For example if the study is for a chronic condition, participants will be followed for a longer period of time. Studies for antibiotics on the other hand are shorter as patients are usually on study for just a few days only.

Some studies and study processes may require you to follow up, and some may not, but you will have the support and guidance of the research team.

As a research participant you have the right to stop the study anytime, the right to get new information about the study and the right to ask questions anytime and get answers immediately.

Yes. Although the study is not for the treatment of any health condition, the study may involve clinical procedures such as MRI, blood tests, hearing tests, etc. To complete these and other tests, the researcher needs to know the volunteer’s general health status to ensure his or her safety during the clinical study.

No, you don’t have to be a US citizen to participate in a clinical trial. We don’t ask for your social security number. All we need is that you have a physical address and some form of ID that we can use during enrollment.

Yes, you can bring a friend or family member to a study; click here.

Who is FOMAT Medical Research?

FOMAT Medical Research is California’s largest research site network, dedicated to advancing clinical research and improving patient outcomes. With an extensive network of research sites and a relentless pursuit of innovation in healthcare through diversity, FOMAT Medical Research works with industry Sponsors and CROs to accelerate the development of new treatments across multiple therapeutic areas. FOMAT is a founding member of hyperCORE International, a network of fully professionalized research site organizations.

FOMAT has done over 25 ulcerative colitis studies and over 100 GI studies. We work with more than 15 gastroenterologists and Principal Investigators in the area to bring new treatments to patients.

Let’s work together to advance ulcerative colitis research

FOMAT Medical Research is committed to ulcerative colitis. Our experience in clinical trials and our pursuit of diversity in research makes us the expert.

FOMAT’s Ulcerative Colitis

  • Experience and Expertise: We have done many studies, we are the experts in ulcerative colitis research. Our team and facilities are designed to deliver quality clinical research.
  • Diversity: We believe diversity in clinical trials means better health outcomes for all. Our research sites are located in diverse communities, so we can enroll a wide range of participants, and our results will be inclusive and applicable to everyone.
  • Collaboration: We work with Sponsors, healthcare professionals, and patients to create an environment that drives innovation and accelerates new treatments.

Meet Our Experts

FOMAT supports ulcerative colitis clinical trials by providing valuable resources and collaboration opportunities with experienced physicians. Our network includes over 20 expert gastroenterologists with extensive experience in ulcerative colitis research.

Karen Simon, M.D.

Karen Simon, MD

Gastroenterologist
Centered Icon and Text
Camarillo & Oxnard, CA
Elias Tarakji, MD

Elias A. Tarakji, MD

Gastroenterologist
Centered Icon and Text
Arcadia, CA
Keval Shah, D.O.

Dr. Keval Shah, DO

Gastroenterologist
Centered Icon and Text
Santa Maria, CA